These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31839374)

  • 21. Ionic Liquid Coating-Driven Nanoparticle Delivery to the Brain: Applications for NeuroHIV.
    Hamadani CM; Mahdi F; Merrell A; Flanders J; Cao R; Vashisth P; Dasanayake GS; Darlington DS; Singh G; Pride MC; Monroe WG; Taylor GR; Hunter AN; Roman G; Paris JJ; Tanner EEL
    Adv Sci (Weinh); 2024 Jun; 11(23):e2305484. PubMed ID: 38572510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymeric nanoparticles for the drug delivery to the central nervous system.
    Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
    Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crossing the Blood-Brain Barrier: A Review on Drug Delivery Strategies for Treatment of the Central Nervous System Diseases.
    Mansor NI; Nordin N; Mohamed F; Ling KH; Rosli R; Hassan Z
    Curr Drug Deliv; 2019; 16(8):698-711. PubMed ID: 31456519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tailoring Lipid and Polymeric Nanoparticles as siRNA Carriers towards the Blood-Brain Barrier - from Targeting to Safe Administration.
    Gomes MJ; Fernandes C; Martins S; Borges F; Sarmento B
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):107-119. PubMed ID: 27209050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanostructures for drug delivery to the brain.
    Martin-Banderas L; Holgado MA; Venero JL; Alvarez-Fuentes J; Fernández-Arévalo M
    Curr Med Chem; 2011; 18(34):5303-21. PubMed ID: 22087827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designing peptide nanoparticles for efficient brain delivery.
    Duro-Castano A; Moreira Leite D; Forth J; Deng Y; Matias D; Noble Jesus C; Battaglia G
    Adv Drug Deliv Rev; 2020; 160():52-77. PubMed ID: 33031897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoneurotoxicity to nanoneuroprotection using biological and computational approaches.
    Iqbal A; Ahmad I; Khalid MH; Nawaz MS; Gan SH; Kamal MA
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2013; 31(3):256-84. PubMed ID: 24024521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution.
    Vergoni AV; Tosi G; Tacchi R; Vandelli MA; Bertolini A; Costantino L
    Nanomedicine; 2009 Dec; 5(4):369-77. PubMed ID: 19341816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration.
    Kadakia E; Bottino D; Amiji M
    Pharm Res; 2019 Mar; 36(5):75. PubMed ID: 30923914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of non-endothelial cells on the penetration of nanoparticles through the blood brain barrier.
    Moura RP; Almeida A; Sarmento B
    Prog Neurobiol; 2017 Dec; 159():39-49. PubMed ID: 28899762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic targeting of leukocyte trafficking across the blood-brain barrier.
    Coisne C; Lyck R; Engelhardt B
    Inflamm Allergy Drug Targets; 2007 Dec; 6(4):210-22. PubMed ID: 18220956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model systems for studies of leukocyte migration across the blood - brain barrier.
    Persidsky Y
    J Neurovirol; 1999 Dec; 5(6):579-90. PubMed ID: 10602399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.
    Sarkar A; Fatima I; Jamal QMS; Sayeed U; Khan MKA; Akhtar S; Kamal MA; Farooqui A; Siddiqui MH
    Curr Drug Metab; 2017; 18(2):129-137. PubMed ID: 28088890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Customizing delivery nano-vehicles for precise brain tumor therapy.
    Miao YB; Zhao W; Renchi G; Gong Y; Shi Y
    J Nanobiotechnology; 2023 Jan; 21(1):32. PubMed ID: 36707835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier.
    Strazielle N; Ghersi-Egea JF
    Curr Pharm Des; 2016; 22(35):5463-5476. PubMed ID: 27464721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
    Crawford L; Rosch J; Putnam D
    J Control Release; 2016 Oct; 240():251-266. PubMed ID: 26724368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.